JP2022031038A - METHOD FOR DETECTING NUMBER OF BACILLUS COAGULANS INCLUDED IN COMPLICATED MICROORGANISM SPECIMEN (VESPOtech(TM)), AND APPLICATION OF THE SAME - Google Patents

METHOD FOR DETECTING NUMBER OF BACILLUS COAGULANS INCLUDED IN COMPLICATED MICROORGANISM SPECIMEN (VESPOtech(TM)), AND APPLICATION OF THE SAME Download PDF

Info

Publication number
JP2022031038A
JP2022031038A JP2020135957A JP2020135957A JP2022031038A JP 2022031038 A JP2022031038 A JP 2022031038A JP 2020135957 A JP2020135957 A JP 2020135957A JP 2020135957 A JP2020135957 A JP 2020135957A JP 2022031038 A JP2022031038 A JP 2022031038A
Authority
JP
Japan
Prior art keywords
spore
lactic acid
acid bacteria
forming lactic
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020135957A
Other languages
Japanese (ja)
Other versions
JP7016391B1 (en
Inventor
陳威仁
Wei Jen Chen
朱慧芳
hui fang Zhu
呉▲シェン▼慧
Shen Hui Wu
周志輝
zhi hui Zhou
蘇秋勇
Qiu Yong Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngen Biotech Co Ltd
Original Assignee
Syngen Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngen Biotech Co Ltd filed Critical Syngen Biotech Co Ltd
Application granted granted Critical
Publication of JP7016391B1 publication Critical patent/JP7016391B1/en
Publication of JP2022031038A publication Critical patent/JP2022031038A/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

To provide a method for detecting the number of bacillus coagulans included in a complicated microorganism specimen (VESPOtechTM), and an application thereof.SOLUTION: Disclosed are a method for detecting the number of bacillus coagulans included in a complicated microorganism specimen (VESPOtechTM), and an application thereof. In the method for detecting the number of bacillus coagulans included in a complicated microorganism specimen, after improved culture medium is provided and a sample to be measured is culture under a prescribed temperature, the total number of bacillus coagulans can be calculated by identifying bacillus coagulans or a colony including their spores on the basis of changes of color on the improved culture medium, and the number of spores of bacillus coagulans can be estimated. The detection method can be used for detecting the presence of activation of bacillus coagulans in the sample or the quality of its activation, and evaluating the function of promoting intestinal health of a bacillus coagulans strain.SELECTED DRAWING: None

Description

特許法第30条第2項適用申請有り Bioscience,Biotechnology,and Biochemistry,Volume 83,Issue 12,令和1年8月12日発行,第2327-2333ページに発表Application for application of Article 30, Paragraph 2 of the Patent Act Bioscience, Biotechnology, and Biotechnology, Volume 83, Issue 12, Reiwa, published on August 12, 1327, pp. 2327-2333

本発明はプロバイオティクスの体外計測方法及びその用途に関し、特に複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)及びその用途に関するものである。 The present invention relates to an in vitro measurement method for probiotics and its use, and particularly to a method for detecting the quantity of spore-forming lactic acid bacteria contained in a complicated microbial sample (VESPOtech TM ) and its use.

有胞子性乳酸菌(Bacillus coagulans)は、バチルスコアグランスとも呼ばれており、乳酸桿菌とバチルス属の特徴を有し、芽胞を形成する特性を有している。研究によれば、有胞子性乳酸菌は、消化器疾患の調整、免疫調整、コレステロールを下げるなどの様々な健康促進効果を有するため、一種のプロバイオティクスと見なされている。しかし、有胞子性乳酸菌は非腸管内性の既存菌種であり、人体が獲得するには自ら摂取しなければならない。 Spore-forming lactic acid bacteria (Bacillus coagulans), also called Bacillus coagulans, have the characteristics of lactic acid bacilli and the genus Bacillus, and have the property of forming spores. Studies have shown that spore-forming lactic acid bacteria are considered a type of probiotic because they have a variety of health-promoting effects, including gastrointestinal disease regulation, immune regulation, and cholesterol lowering. However, spore-forming lactic acid bacteria are existing non-intestinal bacterial species and must be ingested by the human body in order to acquire them.

有胞子性乳酸菌は、胞子形態によって高温又は酸性などの過酷な環境に耐えるため、現在は胃酸などで活性化が破壊されるのを防ぐために、胞子形態の有胞子性乳酸菌を食品又は組成物とすることが多い。但し、有胞子性乳酸菌の胞子が個体に投与された後に腸管内で発芽(germination)しなかった場合には、腸管内での栄養細胞(vegetative cells)への変換及び腸管定着が不可能となるが、これは有胞子性乳酸菌が個体の体内において栄養細胞の生理活性を発揮できないことを意味している。 Spore-forming spore-forming lactic acid bacteria can withstand harsh environments such as high temperature or acidity depending on the spore morphology. I often do it. However, if spores of spore-forming lactic acid bacteria do not germinate in the intestinal tract after being administered to an individual, conversion to vegetative cells and intestinal colonization in the intestinal tract become impossible. However, this means that spore-forming lactic acid bacteria cannot exert the physiological activity of vegetative cells in the body of an individual.

現在の研究では、有胞子性乳酸菌の腸管内における発育機序を完全に理解することができない。また、従来の検出及び解析方法では糞便内の有胞子性乳酸菌及びその他の微生物を分離培養することができず、糞便中からバチルスコアグランスのスクリーニング又は分離を行う専用の培地も未だ提供されていない。また、75℃で30分間処理するなど、短時間の熱処理を通してその他の微生物を除去し、胞子形態の有胞子性乳酸菌の数量を算出する研究が行われているものの、加熱処理は「熱活性化」現象が生じるため、胞子の発芽・増殖が促進されて、誤った結果を得てしまう場合がある。 Current studies do not fully understand the growth mechanism of spore-forming lactic acid bacteria in the intestinal tract. In addition, conventional detection and analysis methods cannot isolate and culture spore-forming lactic acid bacteria and other microorganisms in feces, and a dedicated medium for screening or isolating Bacillus coagul from feces has not yet been provided. .. In addition, although research is being conducted to calculate the number of spore-forming spore-forming lactic acid bacteria in the spore form by removing other microorganisms through a short heat treatment such as treatment at 75 ° C. for 30 minutes, the heat treatment is "heat activation". Because of this phenomenon, spore germination and proliferation may be promoted, resulting in erroneous results.

従って、従来技術では有胞子性乳酸菌が腸管内で発芽したか否かを判断することが難しく、有胞子性乳酸菌の胞子又は有胞子性乳酸菌の胞子を含む組成物が個体内で栄養細胞の活性化を発揮しているか否かを知るのは困難であることが分かる。 Therefore, it is difficult to determine whether or not spore-forming lactic acid bacteria have germinated in the intestinal tract by the prior art, and a composition containing spores of spore-forming lactic acid bacteria or spores of spore-forming lactic acid bacteria is active in the individual. It turns out that it is difficult to know whether or not it is demonstrating.

本発明は、複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)を提供することを主な目的としており、前処理済及び/又は未処理の糞便試料を、改良後の培地で培養し、糞便試料内の有胞子性乳酸菌又は栄養細胞の数量を直接的又は間接的に算出するものである。 The main object of the present invention is to provide a method (VESPOtech TM ) for detecting the number of spore-forming lactic acid bacteria contained in a complex microbial sample, and pretreated and / or untreated fecal samples are used. The number of spore-forming lactic acid bacteria or vegetative cells in the fecal sample is calculated directly or indirectly by culturing in the improved medium.

本発明の別の目的は、複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)の用途を提供することであり、本発明が開示する方法によって糞便試料内の有胞子性乳酸菌及び/又はその胞子の体内における有効性及びその胞子の数量を検出し、有胞子性乳酸菌の胞子が体内で栄養細胞に変換された数量を推計することにより、非侵襲的な方法で有胞子性乳酸菌を含む組成物を正確且つ迅速に評価し、善玉菌の増殖に有利な腸内環境を構築することができる効果を達成するものである。 Another object of the present invention is to provide an application of a method (VESPOtech TM ) for detecting the quantity of spore-forming lactic acid bacteria contained in a complex microbial sample, and the method disclosed by the present invention is used in a fecal sample. A non-invasive method by detecting the efficacy of spore-forming lactic acid bacteria and / or their spores in the body and the number of spores thereof, and estimating the number of spores of spore-forming lactic acid bacteria converted into vegetative cells in the body. The composition containing spore-forming lactic acid bacteria is accurately and quickly evaluated, and the effect of constructing an intestinal environment advantageous for the growth of good bacteria is achieved.

上述の目的を達成するために、本発明は複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)を提供するが、それは、糞便試料を培地に接種して培養し、周囲の色が変化したコロニーを選択して、当該コロニーが有胞子性乳酸菌であるかを判断し、次に当該コロニーをカウントして、当該コロニーの数量を得るものである。 In order to achieve the above-mentioned object, the present invention provides a method (VESPOtech TM ) for detecting the number of spore-forming lactic acid bacteria contained in a complex microbial sample, which is to inoculate a stool sample into a medium and culture it. Then, the colonies whose surrounding colors have changed are selected, it is determined whether or not the colonies are spore-forming lactic acid bacteria, and then the colonies are counted to obtain the quantity of the colonies.

実施例中、糞便試料中の有胞子性乳酸菌の栄養細胞が培地上で増殖できるようにするため、培地に接種する前に、糞便試料に対して次亜塩素酸ナトリウム処理を行う必要がある。 In the examples, in order to allow the vegetative cells of the spore-forming lactic acid bacteria in the stool sample to proliferate on the medium, it is necessary to treat the stool sample with sodium hypochlorite before inoculating the medium.

そのうち、糞便試料に対する次亜塩素酸ナトリウム処理の時間は、約30~60秒とし、例えば30秒、35秒、40秒、45秒、50秒、55秒とするが、処理時間は30秒とするのが好ましい。 Of these, the time for treating the stool sample with sodium hypochlorite is about 30 to 60 seconds, for example, 30 seconds, 35 seconds, 40 seconds, 45 seconds, 50 seconds, 55 seconds, but the treatment time is 30 seconds. It is preferable to do.

そのうち、次亜塩素酸ナトリウムの濃度は1000ppm以下とし、例えば100、200、300、400、500、600、700、800、900ppmとするが、例として、次亜塩素酸ナトリウム濃度が500ppmである場合でも、処理前後における糞便試料中の有胞子性乳酸菌の胞子の数量を安定的に維持することができる。 Among them, the concentration of sodium hypochlorite is 1000 ppm or less, for example, 100, 200, 300, 400, 500, 600, 700, 800, 900 ppm, but as an example, when the sodium hypochlorite concentration is 500 ppm. However, the number of spores of spore-forming lactic acid bacteria in the fecal sample before and after the treatment can be stably maintained.

別の実施例中、本発明が開示する複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)では、糞便試料及び次亜塩素酸ナトリウム処理を経た糞便試料をそれぞれ培養し、有胞子性乳酸菌の総数及びその胞子の数量を算出して、有胞子性乳酸菌の栄養細胞の数量を推計する。具体的には、糞便試料の一部を取り、次亜塩素酸ナトリウムで処理し、次亜塩素酸ナトリウム処理を経た糞便試料及び次亜塩素酸ナトリウム処理を経ていない糞便試料のそれぞれを培地に接種して、培養を行う。培養完了後、培地上のコロニー周囲の色の変化を観察し、それぞれで培地上の周囲に色の変化があった当該コロニーを選択し、且つ当該コロニーの数量をカウントして、当該コロニーが次亜塩素酸ナトリウム処理を経ていない糞便試料からのものである場合、当該コロニーのカウント結果は有胞子性乳酸菌の総数であり、当該コロニーが次亜塩素酸ナトリウム処理を経た糞便試料からのものである場合、当該コロニーのカウント結果は有胞子性乳酸菌の胞子数である。 In another example, in the method for detecting the number of spore-forming lactic acid bacteria contained in the complex microbial sample disclosed by the present invention (VESPOtech TM ), a stool sample and a stool sample treated with sodium hypochlorite are used, respectively. After culturing, the total number of spore-forming lactic acid bacteria and the number of spores thereof are calculated to estimate the number of vegetative cells of the spore-forming lactic acid bacteria. Specifically, a part of the stool sample is taken, treated with sodium hypochlorite, and the stool sample treated with sodium hypochlorite and the stool sample not treated with sodium hypochlorite are inoculated into the medium. Then, culture is performed. After the culture is completed, the color change around the colony on the medium is observed, the colony having the color change around the medium is selected, and the number of the colonies is counted, and the colony is next. If it is from a stool sample that has not been treated with sodium hypochlorite, the count result of the colony is the total number of spore-forming lactic acid bacteria, and the colony is from a stool sample that has been treated with sodium hypochlorite. If so, the count result of the colony is the number of spores of spore-forming lactic acid bacteria.

そのうち、次亜塩素酸ナトリウムの濃度は1000ppm未満とし、例えば500ppmとする。また、糞便試料に対する次亜塩素酸ナトリウム処理の時間は60秒未満であるのが好ましく、例えば30秒又は45秒とする。 Among them, the concentration of sodium hypochlorite is less than 1000 ppm, for example, 500 ppm. The time for treating the stool sample with sodium hypochlorite is preferably less than 60 seconds, for example, 30 seconds or 45 seconds.

また、実施例中、有胞子性乳酸菌の総数から有胞子性乳酸菌の胞子数を差し引くと、有胞子性乳酸菌の栄養細胞の数量を得ることができる。 Further, in the examples, by subtracting the number of spores of the spore-forming lactic acid bacteria from the total number of the spore-forming lactic acid bacteria, the number of vegetative cells of the spore-forming lactic acid bacteria can be obtained.

本発明の実施例中、培地はグルコース酵母エキス寒天培地(GYEA medium)であり、pH値は約5.5である。 In the examples of the present invention, the medium is a glucose yeast extract agar medium (GYEA medium), and the pH value is about 5.5.

本発明の実施例中、pH指示薬はブロモクレゾールグリーンである。 In the examples of the present invention, the pH indicator is bromocresol green.

本発明の実施例中、培養温度は約55℃である。 In the examples of the present invention, the culture temperature is about 55 ° C.

本発明の実施例中、糞便試料の提供者には、試料採取の少なくとも5日前に、有胞子性乳酸菌又は有胞子性乳酸菌を含む組成物を投与する。 In the examples of the present invention, the donor of the fecal sample is administered with a spore-forming lactic acid bacterium or a composition containing the spore-forming lactic acid bacterium at least 5 days before sampling.

さらに、本発明が開示する複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)は、測定対象試料内の有胞子性乳酸菌の胞子の一個体内における酸産生能又は酸産生率を検出又は評価するのに使用することができ、つまり、被験者は測定対象試料を少なくとも5日前に投与され、被験者からの糞便試料を培地で培養して、有胞子性乳酸菌及び/又はその胞子の数量を算出し、有胞子性乳酸菌及びその胞子の数量の差が大きいほど、測定対象試料の被験者内における酸産生能又は酸産生率が優れていることを示すため、これにより、有胞子性乳酸菌株の腸内における健康促進機能の評価が達成される。 Further, the method for detecting the number of spore-forming lactic acid bacteria contained in the complex microbial sample disclosed in the present invention (VESPOTech TM ) is an acid-producing ability in one individual of spore-forming lactic acid bacteria spores in the sample to be measured. It can be used to detect or assess acid production, that is, the subject was administered the sample to be measured at least 5 days in advance, and the fecal sample from the subject was cultured in medium to spore-forming lactic acid bacteria and / or. The number of spores is calculated, and the larger the difference in the number of spore-forming lactic acid bacteria and their spores, the better the acid-producing ability or the acid-producing rate in the subject of the measurement target sample. An assessment of the intestinal health-promoting function of spore-forming lactic acid strains is achieved.

図1中のAは、有胞子性乳酸菌を改良GYEA培地で培養し、コロニー形態を肉眼観察したものである。図1中のBは、有胞子性乳酸菌を改良GYEA培地で培養し、第2段階の培養4日目にコロニー形態を顕微鏡で観察した結果である。図1中のCは、有胞子性乳酸菌を改良GYEA培地で培養し、第2段階の培養5日目にコロニー形態を顕微鏡で観察した結果であり、そのうち、矢印の指す箇所が有胞子性乳酸菌の胞子である。図1中のDは、有胞子性乳酸菌を改良GYEA培地で培養し、第2段階の培養6日目にコロニー形態を顕微鏡で観察した結果であり、そのうち、矢印の指す箇所が有胞子性乳酸菌の胞子である。In FIG. 1, A is a spore-forming lactic acid bacterium cultured in an improved GYEA medium and the colony morphology observed with the naked eye. FIG. 1B is the result of culturing spore-forming lactic acid bacteria in the improved GYEA medium and observing the colony morphology under a microscope on the 4th day of the second stage culture. C in FIG. 1 is the result of culturing spore-forming lactic acid bacteria in the improved GYEA medium and observing the colony morphology under a microscope on the 5th day of the second stage culture. Spores. D in FIG. 1 is the result of culturing the spore-forming lactic acid bacterium in the improved GYEA medium and observing the colony morphology with a microscope on the 6th day of the second stage culture. Spores. 胞子を有する有胞子性乳酸菌コロニーの培養日数別割合である(Duncan's test,p<0.05)。Percentage of spore-bearing spore-forming lactic acid bacteria colonies by culture days (Duncan's test, p <0.05). 異なる濃度の次亜塩素酸ナトリウム処理を経た試料における有胞子性乳酸菌の胞子数の相対的割合であり、そのうち、次亜塩素酸ナトリウム処理を経ていない有胞子性乳酸菌の胞子数を比較基準としている。It is the relative ratio of the number of spores of spore-forming lactic acid bacteria in the samples treated with different concentrations of sodium hypochlorite, and the number of spores of spore-forming lactic acid bacteria not treated with sodium hypochlorite is used as a comparison standard. .. 異なる時間の次亜塩素酸ナトリウム処理を経た試料における有胞子性乳酸菌の胞子数の相対的割合であり、そのうち、次亜塩素酸ナトリウム処理が0秒の有胞子性乳酸菌の胞子数を比較基準としている。Relative ratio of the number of spores of spore-forming lactic acid bacteria in samples treated with sodium hypochlorite for different times, of which the number of spores of spore-forming lactic acid bacteria treated with sodium hypochlorite for 0 seconds is used as a comparison standard. There is. 異なる腸管部分における有胞子性乳酸菌の胞子と栄養細胞それぞれの割合であり、そのうち、a~b間に顕著な差異(p<0.05)があり、c~d間に顕著な差異(Duncan's test,p<0.05)がある。The proportions of spore-forming lactic acid bacteria spores and vegetative cells in different intestinal parts, of which there is a significant difference (p <0.05) between a and b, and a significant difference between c and d (Duncan'. There is s test, p <0.05). 各ラット群の糞便中の短鎖脂肪酸含有量であり、そのうち、*は顕著な差異があることを示している(Duncan's test,p<0.05)。The content of short-chain fatty acids in the feces of each rat group, of which * indicates a significant difference (Duncan's test, p <0.05).

本発明は、複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)及びその用途を開示するが、それは、改良を経た所定のpH値を有する培地を提供し、且つ糞便試料の前処理技術を組み合わせることにより、糞便試料を培地に接種し、所定温度下で培養した後、培地上のコロニー周囲の色の変化により有胞子性乳酸菌が含まれたコロニーを選択且つ判断し、有胞子性乳酸菌の総数及び/又は有胞子性乳酸菌の胞子数を算出するものである。また、有胞子性乳酸菌の総数及び有胞子性乳酸菌の胞子数を得た後、有胞子性乳酸菌の総数と有胞子性乳酸菌の胞子数との間の差値を算出すれば、有胞子性乳酸菌の栄養細胞の数量となり、これにより、測定対象試料内の有胞子性乳酸菌の個体内における酸産生能又は酸産生率を評価することができ、腸管内の弱酸性環境を安定的に維持できるなら、善玉菌が増殖するのに有利となり、且つ悪玉菌の増殖が抑えられるため、本発明が開示する方法は、測定対象試料内の個体内における活性化の有無及びその活性化の良否を推定することで、測定対象試料の有効性を判断する効果を達成することができる。 The present invention discloses a method for detecting the quantity of spore-forming lactic acid bacteria contained in a complex microbial sample (VESPOtech TM ) and its use, which provides a medium having an improved predetermined pH value. In addition, by combining the pretreatment technology of the stool sample, the stool sample is inoculated into the medium, cultured at a predetermined temperature, and then the colony containing spore-forming lactic acid bacteria is selected by the color change around the colony on the medium. Judgment is made, and the total number of spore-forming lactic acid bacteria and / or the number of spores of spore-forming lactic acid bacteria are calculated. In addition, after obtaining the total number of spore-forming lactic acid bacteria and the number of spores of spore-forming lactic acid bacteria, the difference between the total number of spore-forming lactic acid bacteria and the number of spores of spore-forming lactic acid bacteria can be calculated. If it is possible to evaluate the acid-producing ability or acid-producing rate in an individual of spore-forming lactic acid bacteria in the sample to be measured, and to stably maintain a weakly acidic environment in the intestinal tract. , It is advantageous for the growth of good bacteria and the growth of bad bacteria is suppressed. Therefore, the method disclosed in the present invention estimates the presence or absence of activation in an individual in the sample to be measured and the quality of the activation. Therefore, the effect of determining the effectiveness of the sample to be measured can be achieved.

本発明における「判断」とは、コロニーが有胞子性乳酸菌であることをスクリーニングによって確認することを指し、手作業又は機器により行うことができる。 The "judgment" in the present invention refers to confirming that the colony is a spore-forming lactic acid bacterium by screening, and can be performed manually or by equipment.

本発明における「栄養細胞(vegetative cells)」とは、芽胞形成菌が、適正な増殖環境下で胞子形態の休眠状態から再び活性化した状態を指し、栄養細胞は、増殖状態において増殖能を有する。 The "vegetative cells" in the present invention refer to a state in which spore-forming bacteria are reactivated from a dormant state of spore form under an appropriate growth environment, and the vegetative cells have a proliferative ability in the growth state. ..

以下、本発明及びその効果について説明するため、幾つかの実施例を挙げて、実施例の結果と図面を合わせてより詳細に説明する。 Hereinafter, in order to explain the present invention and its effects, some examples will be given, and the results of the examples and the drawings will be described in more detail.

本発明が使用する有胞子性乳酸菌は、「胞子形態のバチルス属純菌株(約5x10胞子/g)」で、生展生物科技股▲分▼有限公司が提供する商用の菌であり、4℃の環境下で保存したものである。この菌株の選択はあくまでも例示に過ぎず、本案の保護範囲を限定するものではなく、生展生物科技股▲分▼有限公司が提供するものではない有胞子性乳酸菌を使用しても本発明の開示する効果を達成することができる。 The spore-forming lactic acid bacterium used in the present invention is a "spore-shaped pure Bacillus strain (about 5x109 9 spores / g)", which is a commercial bacterium provided by Biotechnology Technology Co., Ltd., 4 It was stored in an environment of ℃. The selection of this strain is merely an example and does not limit the scope of protection of the present invention. The disclosed effect can be achieved.

以下の実施例中の動物実験は、いずれも国立中興大学及び使用委員会による承認を経ており、関係する倫理規定を遵守して行われた。 All of the animal experiments in the following examples have been approved by the National Chung Hsing University and the Use Committee, and were conducted in compliance with the relevant ethical code.

以下の実施例における全てのデータは、いずれもダンカンの新多重範囲検定(Duncan's test)により統計解析されたものである。 All the data in the following examples were statistically analyzed by Duncan's new multiplex test (Duncan's test).

複雑な微生物検体中の有胞子性乳酸菌の確認 Confirmation of spore-forming lactic acid bacteria in complex microbial specimens

測定対象の菌試料を取り、先ず改良GYEA(glucose yeast extract agar)培地で培養した。改良条件は、pH値を5.5に調整し、ブロモクレゾールグリーンをpH指示薬とした。55℃の好気性環境下で2日間培養し、温度によって55℃以上の温度では生存できない細菌を除去して、有胞子性乳酸菌コロニー(図1中のAの通り)を残した。有胞子性乳酸菌の増殖により、培養環境中のpH値が約pH3.8に下がったため、有胞子性乳酸菌コロニーの周囲に青から黄色への色の変化が生じ、さらに顕微鏡でコロニーの胞子形成状況を確認すると、周囲が黄色の輪であり且つ胞子を有する青色のコロニーが有胞子性乳酸菌コロニーであることが分かった。第2段階の培養を行ったが、即ち、引き続き55℃の恒温環境下に置いて特定の日数培養した後、黄色の輪を有する有胞子性乳酸菌コロニーを選択し、且つマラカイトグリーン及び蕃紅花で染色して、顕微鏡で観察した。結果は図1中のB~Dに示す通りである。また、胞子を有するコロニーをカウントした結果は図2に示す通りである。 Bacterial samples to be measured were first taken and cultured in an improved GYEA (glucose yeast extract agar) medium. As for the improvement conditions, the pH value was adjusted to 5.5, and bromocresol green was used as a pH indicator. The cells were cultured in an aerobic environment at 55 ° C. for 2 days, and bacteria that could not survive at a temperature of 55 ° C. or higher were removed depending on the temperature, leaving spore-forming lactic acid bacteria colonies (as shown in A in FIG. 1). Due to the growth of spore-forming lactic acid bacteria, the pH value in the culture environment dropped to about pH 3.8, so that the color changed from blue to yellow around the spore-forming lactic acid bacteria colonies, and the spore formation status of the colonies under a microscope. It was found that the blue colonies having yellow rings and spores around them were spore-forming lactic acid bacteria colonies. The second stage culture was performed, that is, after culturing for a specific number of days in a constant temperature environment of 55 ° C., spore-forming lactic acid bacterium colonies having a yellow ring were selected, and malachite green and autumn crocus were used. It was stained and observed under a microscope. The results are as shown in B to D in FIG. The results of counting the colonies having spores are as shown in FIG.

図1中のBは、第2段階の培養4日後、有胞子性乳酸菌コロニーは増殖型の栄養細胞(vegetative form)のみ現れていることを示しているが、第2段階の培養5日目からは、有胞子性乳酸菌コロニー中に胞子が現れ始め、培養日数が増えるにつれて増加していることが分かる(図1中のC及びDの通り)。さらに、図2の結果は、第2段階の培養6日目に、胞子を有する有胞子性乳酸菌コロニーの割合が顕著に増加し、さらに培養7日目には、ほぼ全てのコロニーが胞子を有していたことを示している。 B in FIG. 1 shows that after 4 days of the second stage culture, only proliferative vegetative cells (vegetative form) appear in the spore-forming lactic acid bacteria colonies, but from the 5th day of the second stage culture. It can be seen that spores began to appear in the spore-forming lactic acid bacterium colonies and increased as the number of culture days increased (as shown in C and D in FIG. 1). Furthermore, the results shown in FIG. 2 show that the proportion of spore-bearing spore-forming lactic acid bacteria colonies increased significantly on the 6th day of the second stage culture, and on the 7th day of the culture, almost all colonies had spores. It shows that it was doing.

従って、有胞子性乳酸菌の検出及び培養を行う環境には、下記の条件が含まれている必要がある。55℃の培養温度であること;培養後、少なくとも5日目に胞子形成が観察可能となるが、培養7日目に観察すると効果が良好である;使用する培地は、上述の改良GYEA培地のように、乳酸を生産する細菌が増殖できるようにする必要があり、且つpH値指示薬を有するのが好ましい。 Therefore, the environment for detecting and culturing spore-forming lactic acid bacteria needs to include the following conditions. The culture temperature is 55 ° C.; spore formation can be observed at least 5 days after the culture, but the effect is good when observed on the 7th day of the culture; the medium used is the above-mentioned improved GYEA medium. As such, it is necessary to allow the lactic acid-producing bacteria to grow, and it is preferable to have a pH value indicator.

試料の前処理パラメータの試験(1) Test of sample pretreatment parameters (1)

有胞子性乳酸菌含有試料を、それぞれ異なる濃度(0、500、750、1000ppm)の次亜塩素酸ナトリウムで30秒間処理した後、それぞれ改良GYEA培地に接種して、55℃で2日間培養した後、黄色の輪を有するコロニーを選択し、コロニーの菌数をカウントして、有胞子性乳酸菌の胞子数を得た。結果は表1に示す通りである。そのうち、各データ間には顕著な差異(Duncan's test,p<0.05)があった。さらに、次亜塩素酸ナトリウムで処理していない有胞子性乳酸菌の胞子数を基準として、異なる濃度の次亜塩素酸ナトリウム処理を経た有胞子性乳酸菌の胞子の相対的割合を算出した。結果は図3に示す通りである。 Samples containing spore-forming lactic acid bacteria were treated with different concentrations (0, 500, 750, 1000 ppm) of sodium hypochlorite for 30 seconds, then inoculated into the improved GYEA medium and cultured at 55 ° C. for 2 days. , Colonies with a yellow ring were selected and the number of colonies was counted to obtain the number of spores of spore-forming lactic acid bacteria. The results are shown in Table 1. Among them, there was a remarkable difference (Duncan's test, p <0.05) between each data. Furthermore, the relative proportion of spores of spore-forming lactic acid bacteria treated with different concentrations of sodium hypochlorite was calculated based on the number of spores of spore-forming lactic acid bacteria not treated with sodium hypochlorite. The results are as shown in FIG.

次亜塩素酸ナトリウムで試料を処理する目的は、有胞子性乳酸菌の栄養細胞を除去し、且つ有胞子性乳酸菌の胞子数を安定的に維持することで、培養後に得られる有胞子性乳酸菌の胞子数を正確にすることであるため、次亜塩素酸ナトリウムで処理した試料中の有胞子性乳酸菌の胞子数は、次亜塩素酸ナトリウム処理を経ていない試料中の有胞子性乳酸菌の胞子数に近いほど、より好適である。 The purpose of treating the sample with sodium hypochlorite is to remove the spore-forming spore-forming spore-forming spores by removing the spore-forming spore-forming spores and maintaining a stable spore count of the spore-forming spore-forming spores. The number of spores of spore-forming lactic acid bacteria in the sample treated with sodium hypochlorite is the number of spores of spore-forming spores in the sample not treated with sodium hypochlorite because the number of spores is to be accurate. The closer it is, the more suitable it is.

表1及び図3の結果から、試料がより高濃度の次亜塩素酸ナトリウム処理を経るほど、そのうちの有胞子性乳酸菌の胞子数がより少なくなることが分かる。これは、高濃度の次亜塩素酸ナトリウムは試料中の有胞子性乳酸菌の胞子数を処理前と大差なく安定的に維持することができないことを意味している。従って、表1及び図3の結果から、試料中の有胞子性乳酸菌の栄養細胞を除去し、且つ有胞子性乳酸菌の胞子数を維持することを同時に達成するには、使用する次亜塩素酸ナトリウム濃度が1000ppmを超えてはならず、また、濃度は約500ppmが好適であることが分かる。 From the results in Table 1 and FIG. 3, it can be seen that the higher the concentration of sodium hypochlorite treatment on the sample, the lower the number of spores of spore-forming lactic acid bacteria. This means that high concentrations of sodium hypochlorite cannot maintain the spore count of spore-forming lactic acid bacteria in the sample in a stable manner, which is not much different from that before the treatment. Therefore, from the results of Table 1 and FIG. 3, the hypochlorite used to simultaneously remove the spore-forming lactic acid bacteria vegetative cells in the sample and simultaneously achieve the maintenance of the spore count of the spore-forming lactic acid bacteria. It can be seen that the sodium concentration should not exceed 1000 ppm and a concentration of about 500 ppm is suitable.

Figure 2022031038000001
Figure 2022031038000001

試料の前処理パラメータの試験(2) Test of sample pretreatment parameters (2)

有胞子性乳酸菌試料を、それぞれ濃度500ppmの次亜塩素酸ナトリウムで異なる時間(0、30、60、180秒)処理した後、それぞれ改良GYEA培地に接種して、55℃で2日間培養した後、黄色の輪を有するコロニーを選択し、コロニーの菌数をカウントして、有胞子性乳酸菌の胞子数を得た。結果は表2に示す通りである。そのうち、各データ間には顕著な差異(Duncan's test,p<0.05)があった。さらに、次亜塩素酸ナトリウムで処理していない有胞子性乳酸菌の胞子数を基準として、異なる時間の次亜塩素酸ナトリウム処理を経た後の有胞子性乳酸菌の胞子の相対的割合を算出した。結果は図4に示す通りである。上述したように、次亜塩素酸ナトリウム処理を経た後の試料中の有胞子性乳酸菌の胞子数と、次亜塩素酸ナトリウム処理を経ていない試料中の有胞子性乳酸菌の胞子数との差がより大きいほど、有胞子性乳酸菌の胞子数を安定的に維持することができないことを示している。 Spore-forming lactic acid bacteria samples were treated with sodium hypochlorite at a concentration of 500 ppm for different times (0, 30, 60, 180 seconds), then inoculated into the improved GYEA medium and cultured at 55 ° C. for 2 days. , Colonies with a yellow ring were selected and the number of colonies was counted to obtain the number of spores of spore-forming lactic acid bacteria. The results are shown in Table 2. Among them, there was a remarkable difference (Duncan's test, p <0.05) between each data. Furthermore, the relative proportion of spores of spore-forming lactic acid bacteria after undergoing sodium hypochlorite treatment for different times was calculated based on the number of spores of spore-forming lactic acid bacteria not treated with sodium hypochlorite. The results are as shown in FIG. As described above, the difference between the number of spore-forming spores in the sample after sodium hypochlorite treatment and the number of spore-forming spores in the sample not treated with sodium hypochlorite is The larger the value, the more difficult it is to maintain a stable spore count of spore-forming lactic acid bacteria.

表2及び図4の結果から、30秒間の次亜塩素酸ナトリウム溶液処理を経た後の試料中の有胞子性乳酸菌の胞子数は、次亜塩素酸ナトリウム処理を経ていないものに近く、試料が60秒間の次亜塩素酸ナトリウム処理を経た場合には、そのうちの有胞子性乳酸菌の胞子数が次亜塩素酸ナトリウム処理を経ていない試料よりも減少しており、試料が180秒間の次亜塩素酸ナトリウム処理を経た場合には、そのうちの有胞子性乳酸菌の胞子数が次亜塩素酸ナトリウム処理を経ていない試料中の有胞子性乳酸菌の胞子数よりも大幅に増加していた。上述の結果は、試料中の有胞子性乳酸菌の栄養細胞を除去し、且つ有胞子性乳酸菌の胞子数を維持することを同時に達成するには、次亜塩素酸ナトリウムで試料を処理する時間は60秒以下でなければならず、また、処理時間は約30秒が好適であることを示している。 From the results of Table 2 and FIG. 4, the number of spores of spore-forming lactic acid bacteria in the sample after being treated with sodium hypochlorite solution for 30 seconds was close to that without sodium hypochlorite treatment, and the sample was After 60 seconds of sodium hypochlorite treatment, the number of spores of spore-forming lactic acid bacteria was lower than that of the sample not treated with sodium hypochlorite, and the sample was hypochlorite for 180 seconds. When treated with sodium hypochlorite, the number of spores of spore-forming lactic acid bacteria was significantly higher than the number of spores of spore-forming lactic acid bacteria in the sample not treated with sodium hypochlorite. The above results show that the time to treat the sample with sodium hypochlorite is to simultaneously achieve the removal of spore-forming lactic acid spore-free cells in the sample and the maintenance of the spore count of the spore-forming spores. It should be 60 seconds or less, and the processing time is preferably about 30 seconds.

Figure 2022031038000002
Figure 2022031038000002

動物実験 Animal experimentation

8週齢雄性SDラット(台湾、BioLASCO公司から購入)16匹を取り、体重はそれぞれ336.6±16.7gであり、22±1℃、湿度60±5%、12時間明暗サイクルの制御環境内で飼育した。 16 8-week-old male SD rats (purchased from BioLASCO Ltd., Taiwan) were taken, each weighing 336.6 ± 16.7 g, 22 ± 1 ° C, humidity 60 ± 5%, and a 12-hour light-dark cycle control environment. Raised in the house.

SDラットをランダムに2群に分け、そのうちの1群をコントロール群、もう1群を有胞子性乳酸菌群(以下はBC菌群と略称する)とし、試験期間中は各ラット群に同じ飲食を供給したが、異なる点として、BC菌群には有胞子性乳酸菌の胞子(5x10 CFU/g)を毎日投与した。試験期間中、各SDラット群の摂食量及び体重を毎日記録し、試験28日目に新鮮な糞便を採取した。採取した糞便を-20℃の環境で保存した。試験終了後、各SDラット群は犠牲にした。 SD rats were randomly divided into two groups, one of which was the control group and the other was the spore-forming lactic acid bacterium group (hereinafter abbreviated as BC bacterium group), and the same food and drink was given to each rat group during the test period. The BC group was supplied with spores of spore-forming lactic acid bacteria ( 5x107 CFU / g) daily. During the test period, food intake and body weight of each SD rat group were recorded daily, and fresh feces were collected on the 28th day of the test. The collected feces were stored in an environment of −20 ° C. After the test was completed, each SD rat group was sacrificed.

記録の結果によれば、SDラットの平均摂食量は28.4~28.9g/dayであり、且つ試験終了における平均最終体重は434.3~439.0gであった。 According to the results of the recording, the average food intake of SD rats was 28.4 to 28.9 g / day, and the average final body weight at the end of the test was 434.3 to 439.0 g.

腸管及び糞便中の細菌形態の検出 Detection of bacterial morphology in the intestinal tract and feces

各ラット群の糞便を採取し、糞便の含水率、重量及びpH値を検出した。結果は表3に示す通りである。 Feces of each rat group were collected, and the water content, weight and pH value of the feces were detected. The results are shown in Table 3.

ラットの盲腸液、結腸内容物及び糞便を採取し、それぞれ1:10(w/v)の割合で無菌リン酸緩衝生理食塩水中に懸濁させた。リン酸緩衝生理食塩水で10倍に連続希釈して、細菌のカウントに必要な濃度を得た。 Rat cecal fluid, colon contents and feces were collected and suspended in sterile phosphate buffered saline at a ratio of 1:10 (w / v), respectively. It was continuously diluted 10-fold with phosphate buffered saline to give the concentration required for bacterial count.

有胞子性乳酸菌の胞子をカウント(spore counts,SCs)するため、改良GYEA培地に塗布する前に、各ラット群の糞便を取り、先にそれぞれ濃度500ppmの次亜塩素酸ナトリウム(NaOCl)溶液で30秒間処理した。 To count the spores of spore-forming lactic acid bacteria (spore counts, SCs), take the feces of each rat group before applying to the improved GYEA medium, and first use a solution of sodium hypochlorite (NaOCl) at a concentration of 500 ppm. Processed for 30 seconds.

各ラット群の次亜塩素酸ナトリウム溶液処理を経ていない糞便及び次亜塩素酸ナトリウム溶液処理を経た糞便を、改良GYEA培地上で55℃下において2日間培養し、黄色い輪を有するコロニーを選択して、コロニーの菌数をカウントし、コロニーが次亜塩素酸ナトリウム溶液処理を経ていない糞便からのものである場合、カウントされた数量は有胞子性乳酸菌の総カウント数(total viable counts,TCs)であり、栄養細胞及び胞子を含むが、コロニーが次亜塩素酸ナトリウム溶液処理を経た糞便からのものである場合、カウントされた数量は有胞子性乳酸菌の胞子数であり、次に有胞子性乳酸菌の総カウント数から有胞子性乳酸菌の胞子数を引くと、栄養細胞の数量が得られる。結果は表4及び図5の通りである。表4中、数量が1x10 CFU/g未満は未検出であった。 The stools that had not been treated with sodium hypochlorite solution and the stools that had been treated with sodium hypochlorite solution of each rat group were cultured on the improved GYEA medium at 55 ° C. for 2 days, and colonies having a yellow ring were selected. If the number of colonies is counted and the colonies are from stool that has not been treated with sodium hypochlorite solution, the counted quantity is the total count of spore-forming lactic acid bacteria (TCs). And containing vegetative cells and spores, but if the colonies are from stool treated with sodium hypochlorite solution, the counted quantity is the spore count of spore-forming lactic acid bacteria, then spore-forming. Subtracting the spore count of spore-forming lactic acid bacteria from the total count of lactic acid bacteria gives the number of vegetative cells. The results are shown in Table 4 and FIG. In Table 4, the quantity less than 1x10 2 CFU / g was not detected.

全てのコロニーはいずれも実施例1に示す方法の処理を経ており、且つ下記のRNAプライマー対により16S rRNAの確認を行っており、結果によって、本実施例中で検出及びカウントしたコロニーと、NCBI BLASTのデータベース中の有胞子性乳酸菌との類似度は99.8%であると確定することができ、本実施例中で培養されたコロニーはいずれも有胞子性乳酸菌コロニーであることが示された。 All colonies have undergone the treatment of the method shown in Example 1, and 16S rRNA has been confirmed by the following RNA primer pair. Based on the results, the colonies detected and counted in this example and NCBI The similarity to spore-forming lactic acid bacteria in the BLAST database could be determined to be 99.8%, indicating that all colonies cultured in this example were spore-forming lactic acid bacteria colonies. rice field.

フォワードプライマー(F):5'-AGAGTTTGATCCTGGCTCAG-3'; Forward primer (F): 5'-AGAGTTTGATCCTGGCTCAG-3';

リバースプライマー(R):5'-ACGGTTACCTTGTTACGACTT-3'。 Reverse primer (R): 5'-ACGGTTACCTTGTTACGACTT-3'.

Figure 2022031038000003
Figure 2022031038000003

Figure 2022031038000004
Figure 2022031038000004

表3の結果から、コントロール群と比較すると、有胞子性乳酸菌の胞子を投与することで、糞便の湿度が増加し、重量を増加させることができるだけでなく、有胞子性乳酸菌が乳酸を生成するため、糞便のpH値を低下させることが分かる。 From the results in Table 3, compared with the control group, administration of spore-forming lactic acid bacteria not only increases the humidity and weight of feces, but also the spore-forming lactic acid bacteria produce lactic acid. Therefore, it can be seen that the pH value of feces is lowered.

表4の結果から、コントロール群中、有胞子性乳酸菌の胞子の存在は検出されず、BC菌群は、連続28日間の有胞子性乳酸菌の胞子の経口試験を経た後、SDラットの糞便中にそれぞれ3.64x10 CFU/gの胞子と6.31x10 CFU/gの栄養細胞を発見することができた。 From the results in Table 4, the presence of spores of spore-forming lactic acid bacteria was not detected in the control group, and the BC bacterium group was subjected to an oral test of spores of spore-forming lactic acid bacteria for 28 consecutive days and then in the feces of SD rats. We were able to find spores of 3.64x10 5 CFU / g and vegetative cells of 6.31x10 5 CFU / g, respectively.

さらに、図5の結果から、BC菌群のSDラットの盲腸液、結腸内容物及び糞便中、有胞子性乳酸菌の胞子と有胞子性乳酸菌の栄養細胞との割合は、それぞれ2.3:7.7、2.1:7.9及び3.9:6.1であった。この結果は、有胞子性乳酸菌の栄養細胞が腸管と糞便のいずれにも出現し、且つ盲腸及び結腸における割合が糞便中を上回ることを示しており、有胞子性乳酸菌の胞子再形成(resporulation)が結腸の遠位、排便前に生じていることが推測できる。 Furthermore, from the results of FIG. 5, the ratio of spores of spore-forming lactic acid bacteria to vegetative cells of spore-forming lactic acid bacteria in the cecal fluid, colon contents and feces of SD rats of the BC bacteria group was 2.3: 7, respectively. It was 0.7, 2.1: 7.9 and 3.9: 6.1. This result indicates that vegetative cells of spore-forming lactic acid bacteria appear in both the intestinal tract and feces, and the proportion in the cecum and colon is higher than that in feces, and the spore regeneration of spore-forming lactic acid bacteria. It can be inferred that this occurs distal to the colon, before defecation.

上述の結果から、本発明が開示する方法によって糞便を培養すると、確かに糞便中の有胞子性乳酸菌の総数及び有胞子性乳酸菌の胞子数を知ることができ、これにより、有胞子性乳酸菌の栄養細胞数を正確且つ迅速に推計可能であり、有胞子性乳酸菌の栄養細胞数が増加若しくは比較的高い場合、又は有胞子性乳酸菌の胞子数が減少若しくは低下した場合、その有胞子性乳酸菌株が腸管内で発芽でき、例えば良好な酸産生能を有するなど、栄養細胞の健康促進効果が発揮されることを示している。反対に、有胞子性乳酸菌の栄養細胞数が減少若しくは比較的低い場合、又は有胞子性乳酸菌の胞子数が増加若しくは比較的高い場合、その有胞子性乳酸菌株の健康促進効果は良くないことを示している。 From the above results, when stool is cultured by the method disclosed by the present invention, the total number of spore-forming lactic acid bacteria and the number of spore-forming spore-forming spores in the stool can be known. The number of vegetative cells can be estimated accurately and quickly, and if the number of spore-forming lactic acid cells increases or is relatively high, or if the number of spore-forming spores decreases or decreases, the spore-forming lactic acid strain. It has been shown that spores can germinate in the intestinal tract and exert a health-promoting effect on vegetative cells, for example, having a good acid-producing ability. On the contrary, when the number of spore-forming lactic acid bacteria is decreased or relatively low, or when the number of spore-forming lactic acid bacteria is increased or relatively high, the health promoting effect of the spore-forming lactic acid bacterium is not good. Shows.

従って、本発明が開示する方法は、消化管内で有胞子性乳酸菌が発芽して栄養細胞となる能力を知るのに用いることができ、これにより、個体内に投与されて入った有胞子性乳酸菌株が腸管の健康改善又は維持に役立ち得るか否かの評価に用いることができる。 Therefore, the method disclosed in the present invention can be used to know the ability of spore-forming lactic acid bacteria to germinate and become vegetative cells in the gastrointestinal tract, whereby the spore-forming lactic acid bacteria administered and entered into an individual can be used. It can be used to assess whether a strain can help improve or maintain intestinal health.

糞便中の短鎖脂肪酸の検出 Detection of short-chain fatty acids in feces

最初に糞便試料を1:10(w/v)の割合で0.9%(w/v)の冷塩水と均質化し、1006gで10分間遠心分離した後、上澄み液2mLを取り、イソカプロン酸10μL(内部標準)及び硫酸20μL 50%(w/v)と混合し、エチルエーテルで抽出した後、カラム(Agilent J&W HP-INNO Wax GC Column,30m,0.25mm. 0.25μm)を用いてガスクロマトグラフ/水素炎イオン化型検出器でエーテル層1μLを解析し、そのうち、7mL/minの流速でヘリウムガスをキャリアガスとして提供した。解析条件は以下の通りである。初期オーブン温度80℃下で1分間、20℃/minの速度で140℃まで昇温、その後140℃下で1分間、次に20℃/minの速度で220℃まで昇温、220℃で2分間。サンプルインジェクターと検出器の温度はそれぞれ140℃と250℃とした。各ラット群の糞便中の短鎖脂肪酸の検出結果は図6に示す通りである。 First, the fecal sample is homogenized with 0.9% (w / v) cold salt water at a ratio of 1:10 (w / v), centrifuged at 1006 g for 10 minutes, then 2 mL of the supernatant is taken and 10 μL of isocaproic acid is taken. (Internal standard) and 20 μL of sulfuric acid 50% (w / v) are mixed, extracted with ethyl ether, and then gas chromatographed using a column (Agilent J & W HP-INNO Wax GC Volume, 30 m, 0.25 mm. 0.25 μm). 1 μL of the ether layer was analyzed with a Tograph / Agilent ionized detector, of which helium gas was provided as a carrier gas at a flow rate of 7 mL / min. The analysis conditions are as follows. Initial oven temperature 80 ° C. for 1 minute, 20 ° C./min rate to 140 ° C., then 140 ° C. for 1 minute, then 20 ° C./min rate to 220 ° C., 220 ° C. 2 Minutes. The temperatures of the sample injector and the detector were 140 ° C and 250 ° C, respectively. The detection results of short-chain fatty acids in feces of each rat group are as shown in FIG.

図6の結果から、BC菌群のSDラットは、有胞子性乳酸菌の胞子が投与されたことで、酢酸(96.1から147.7mol/g糞便)及び酪酸(34.9から99.0mol/g糞便)の急激な上昇が生じたが、プロピオン酸の含有量は顕著に上昇しなかったことが分かる。全体的には、有胞子性乳酸菌の胞子を投与した後、胞子の発芽・増殖が短鎖脂肪酸の総濃度を約1.7倍(169.3から279.2mol/g糞便)に高めることができた。 From the results shown in FIG. 6, SD rats in the BC group were treated with acetic acid (96.1 to 147.7 mol / g feces) and butyric acid (34.9 to 99.0 mol) due to the administration of spores of spore-forming lactic acid bacteria. / G Feces) increased sharply, but the content of propionic acid did not increase significantly. Overall, after administration of spores of spore-forming lactic acid bacteria, germination and proliferation of spores can increase the total concentration of short-chain fatty acids by about 1.7 times (169.3 to 279.2 mol / g feces). did it.

この結果を前述の実施例の結果と総合すると、有胞子性乳酸菌の胞子が消化管内で活性化されて栄養細胞になると、消化管内で乳酸などの物質が生成され、元々消化管内に常在する酸生成細菌(acid-producing bacteria)を増殖且つ酸産生することができるようにし、これにより、消化管内の短鎖脂肪酸の総濃度を高めることが合理的に理解できる。 When this result is combined with the results of the above-mentioned Examples, when the spores of spore-forming lactic acid bacteria are activated in the gastrointestinal tract and become vegetative cells, substances such as lactic acid are produced in the gastrointestinal tract and originally reside in the gastrointestinal tract. It is reasonably understood that acid-producing bacteria can grow and produce acid, thereby increasing the total concentration of short-chain fatty acids in the gastrointestinal tract.

前述の実施例の結果を総合すると、本発明が開示する複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)は、糞便試料中に含まれる有胞子性乳酸菌の数量及び有胞子性乳酸菌の胞子数を検出することにより、糞便試料の提供者の体内に入った有胞子性乳酸菌が活性化又は再発芽して栄養細胞になることができたか否かを知ることができ、体内に入った有胞子性乳酸菌の胞子が栄養細胞に変換された数量が高い場合、体内に投与された有胞子性乳酸菌又は有胞子性乳酸菌を含む組成物が良好な生理活性を有しており、腸内環境を改善し、腸内の健康を促進し得ることを示している。 Combining the results of the above-mentioned examples, the method for detecting the number of spore-forming lactic acid bacteria contained in the complex microbial sample disclosed in the present invention (VESPOtech TM ) is a method for detecting spore-forming lactic acid bacteria contained in a fecal sample. By detecting the quantity and the number of spores of spore-forming lactic acid bacteria, it is possible to know whether or not the spore-forming lactic acid bacteria that entered the body of the donor of the fecal sample could be activated or re-emergent to become vegetative cells. When the amount of spores of spore-forming lactic acid bacteria that have entered the body is high, the composition containing spore-forming lactic acid bacteria or spore-forming lactic acid bacteria administered into the body has good physiological activity. It has been shown that it can improve the intestinal environment and promote intestinal health.

Claims (8)

糞便試料を得る工程と、
前記糞便試料を次亜塩素酸ナトリウムで30~60秒処理する工程と、
培地を調製する工程と、
次亜塩素酸ナトリウム処理を経た前記糞便試料及び次亜塩素酸ナトリウム処理を経ていない糞便試料のそれぞれを培地に接種し、50℃~60℃の培養温度下で培養する工程と、
培養完了後、前記培地上のコロニー周囲の色の変化を観察し、それぞれの培地上で周囲に色の変化があった前記コロニーを選択して、前記コロニーの菌数をカウントする工程と、を含み、
前記培地のpH値は5.0~6.0であり、乳酸を生成する細菌の増殖のために提供される栄養成分と、pH指示薬として用いられるブロモクレゾールグリーンを有し、
前記コロニーが次亜塩素酸ナトリウム処理を経ていない前記糞便試料からのものである場合、前記コロニーのカウント結果は有胞子性乳酸菌の総数であり、前記コロニーが次亜塩素酸ナトリウム処理を経た前記糞便試料からのものである場合、前記コロニーのカウント結果は有胞子性乳酸菌の胞子数である、複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)。
The process of obtaining a stool sample and
A step of treating the stool sample with sodium hypochlorite for 30 to 60 seconds, and
The process of preparing the medium and
A step of inoculating each of the stool sample treated with sodium hypochlorite and the stool sample not treated with sodium hypochlorite into a medium and culturing at a culture temperature of 50 ° C. to 60 ° C.
After the culture is completed, the step of observing the color change around the colony on the medium, selecting the colony having the color change in the surroundings on each medium, and counting the number of bacteria in the colony. Including,
The medium has a pH value of 5.0-6.0 and has a nutritional component provided for the growth of lactic acid-producing bacteria and bromocresol green used as a pH indicator.
When the colony is from the stool sample that has not been treated with sodium hypochlorite, the count result of the colony is the total number of spore-forming lactic acid bacteria, and the colony is the stool that has been treated with sodium hypochlorite. When it is from a sample, the count result of the colony is the number of spores of spore-forming lactic acid bacteria, which is a method for detecting the number of spore-forming lactic acid bacteria contained in a complex microbial sample (VESPOtech TM ).
次亜塩素酸ナトリウムの濃度は500ppmである、請求項1に記載の複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)。 The method for detecting the quantity of spore-forming lactic acid bacteria contained in the complex microbial sample according to claim 1, wherein the concentration of sodium hypochlorite is 500 ppm (VESPOtech TM ). 前記糞便試料に対する次亜塩素酸ナトリウム処理の時間は30秒である、請求項1に記載の複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)。 The method for detecting the number of spore-forming lactic acid bacteria contained in the complex microbial sample according to claim 1, wherein the time for treating the stool sample with sodium hypochlorite is 30 seconds (VESPOtech TM ). 前記有胞子性乳酸菌の総数から前記有胞子性乳酸菌の胞子数を差し引き、有胞子性乳酸菌の栄養細胞の数量を得る、請求項1に記載の複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)。 The spore-forming lactic acid bacterium contained in the complex microbial sample according to claim 1, wherein the number of spores of the spore-forming lactic acid bacterium is subtracted from the total number of the spore-forming lactic acid bacteria to obtain the number of vegetative cells of the spore-forming lactic acid bacterium. A method for detecting a quantity (VESPOtech TM ). 前記培地はグルコース酵母エキス寒天培地であり、pH値は約5.5である、請求項1に記載の複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)。 The method for detecting the number of spore-forming lactic acid bacteria contained in the complex microbial sample according to claim 1, wherein the medium is a glucose yeast extract agar medium and the pH value is about 5.5 (VESPOtech TM ). 前記培養温度は約55℃である、請求項1に記載の複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)。 The method for detecting the quantity of spore-forming lactic acid bacteria contained in the complex microbial sample according to claim 1, wherein the culture temperature is about 55 ° C. (VESPOtech TM ). 前記糞便試料の提供者には、試料採取の少なくとも5日前に、有胞子性乳酸菌又は有胞子性乳酸菌を含む組成物を投与する、請求項1に記載の複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)。 The spores contained in the complex microbial sample according to claim 1, wherein the donor of the fecal sample is administered with a composition containing spore-forming lactic acid bacteria or spore-forming lactic acid bacteria at least 5 days before sampling. A method for detecting the quantity of sex lactic acid bacteria (VESPOtech TM ). 測定対象試料内の有胞子性乳酸菌の胞子の個体内における酸産生能を評価するのに用いることができる、請求項1~請求項7のいずれか1項に記載の複雑な微生物検体中に含まれる有胞子性乳酸菌の数量を検出する方法(VESPOtechTM)の用途。 The complex microbial sample according to any one of claims 1 to 7, which can be used to evaluate the acid-producing ability of spores of spore-forming lactic acid bacteria in a sample to be measured. A method for detecting the quantity of spore-forming lactic acid bacteria (VESPOtech TM ).
JP2020135957A 2020-08-05 2020-08-11 Method for detecting the quantity of spore-forming lactic acid bacteria contained in a complex microbial sample (VESPOtech (TM)) and its use Active JP7016391B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TW109126556A TWI775126B (en) 2020-08-05 2020-08-05 Method for detecting the number of spore lactic acid bacteria in a sample containing complex microorganisms and its use
TW109126556 2020-08-05

Publications (2)

Publication Number Publication Date
JP7016391B1 JP7016391B1 (en) 2022-02-04
JP2022031038A true JP2022031038A (en) 2022-02-18

Family

ID=80324538

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020135957A Active JP7016391B1 (en) 2020-08-05 2020-08-11 Method for detecting the quantity of spore-forming lactic acid bacteria contained in a complex microbial sample (VESPOtech (TM)) and its use

Country Status (2)

Country Link
JP (1) JP7016391B1 (en)
TW (1) TWI775126B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115141781B (en) * 2022-05-07 2023-06-16 青岛农业大学 Method for improving content of ferrous ions in bacillus coagulans and composite microbial inoculum

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06113823A (en) * 1991-09-18 1994-04-26 Horinouchi Kanzume Kk Detection of viable cell count and culture medium therefor
CN101659983A (en) * 2009-09-28 2010-03-03 上海创博生态工程有限公司 Method for detecting number of viable bacillus
JP2016192955A (en) * 2015-03-31 2016-11-17 第一公害プラント株式会社 Method of counting genus bacillus bacteria
JP2019535770A (en) * 2016-11-24 2019-12-12 サミ ラブズ リミテッド Stable probiotic composition containing Bacillus coagulans MTCC5856 and method for detecting the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3652330A4 (en) * 2017-07-12 2021-01-06 Ecolab USA Inc. A rapid approach for detection of bacterial spores
CN110643673B (en) * 2019-08-27 2023-08-08 湖北华扬科技发展有限公司 Counting method of bacillus coagulans spores in feeding composite microecological product

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06113823A (en) * 1991-09-18 1994-04-26 Horinouchi Kanzume Kk Detection of viable cell count and culture medium therefor
CN101659983A (en) * 2009-09-28 2010-03-03 上海创博生态工程有限公司 Method for detecting number of viable bacillus
JP2016192955A (en) * 2015-03-31 2016-11-17 第一公害プラント株式会社 Method of counting genus bacillus bacteria
JP2019535770A (en) * 2016-11-24 2019-12-12 サミ ラブズ リミテッド Stable probiotic composition containing Bacillus coagulans MTCC5856 and method for detecting the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF FOOD SCIENCE, vol. Vol. 74, Nr. 4, JPN6021035467, 2009, pages 185 - 189, ISSN: 0004657398 *

Also Published As

Publication number Publication date
TW202206603A (en) 2022-02-16
JP7016391B1 (en) 2022-02-04
TWI775126B (en) 2022-08-21

Similar Documents

Publication Publication Date Title
de Melo Pereira et al. How to select a probiotic? A review and update of methods and criteria
Anandharaj et al. Isolation of potential probiotic Lactobacillus oris HMI68 from mother's milk with cholesterol-reducing property
Yerlikaya et al. In vitro characterisation of probiotic properties of Enterococcus faecium and Enterococcus durans strains isolated from raw milk and traditional dairy products
Čitar et al. Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cells
Wang et al. In vitro assessment of probiotic properties of Bacillus isolated from naturally fermented congee from Inner Mongolia of China
Ratanaburee et al. Selection of γ‐aminobutyric acid‐producing lactic acid bacteria and their potential as probiotics for use as starter cultures in T hai fermented sausages (N ham)
Kılıç et al. Identification of lactic acid bacteria isolated from the fecal samples of healthy humans and patients with dyspepsia, and determination of their pH, bile, and antibiotic tolerance properties
JP5875975B2 (en) Probiotic microorganisms isolated from donkey milk
Perelmuter et al. In vitro activity of potential probiotic Lactobacillus murinus isolated from the dog
JP2013531506A (en) Use of LACTOBACILLI to inhibit gas-producing coliforms isolated from infants suffering from colic
AU2020103929A4 (en) Bacillus coagulans strain BACO-17 with high germination rate in the intestines and its uses for promoting gastrointestinal health
Strompfová et al. Isolation and characterization of faecal bifidobacteria and lactobacilli isolated from dogs and primates
CN113564272B (en) Rapid identification and detection method for cheese lactobacillus in fermented milk
Sadrani et al. Screening of potential probiotic Lactobacillus strains isolated from fermented foods, fruits and of human origin
Abdi et al. Interesting probiotic traits of mother's milk Lactobacillus isolates; from bacteriocin to inflammatory bowel disease improvement
CN114350578A (en) Lactobacillus plantarum LP1Z for producing lysozyme and efficiently antagonizing multidrug-resistant helicobacter pylori and application thereof
JP7016391B1 (en) Method for detecting the quantity of spore-forming lactic acid bacteria contained in a complex microbial sample (VESPOtech (TM)) and its use
Zago et al. Detection and quantification of Enterococcus gilvus in cheese by real-time PCR
KR100435505B1 (en) Lactobacillus plantarum isolated from kimchi with inhibiting activities on helicobacter pylori
KR101201420B1 (en) A feed additive containing novel Lactobacillus jonhsonnii
EP3793580A1 (en) Probiotic strain lactobacillus kefiri sgl 13 and use thereof for the prevention and treatment of intestinal inflammation and in the prevention of intestinal neoplasms
Pato et al. Bile and acid tolerance of lactic acid bacteria isolated from tempoyak and their probiotic potential.
CN113881592A (en) Lactobacillus reuteri and application thereof
karasu Ramasamy et al. Molecular characterization of lactobacillus sp, from Indian curd and its Antagonistic effects on uropathogens of Diabetic patients
Kocabay Evaluation of probiotic properties of Levilactobacillus brevis isolated from hawthorn vinegar

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200914

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200914

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20200909

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210914

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211025

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211207

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211217

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220118

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220125

R150 Certificate of patent or registration of utility model

Ref document number: 7016391

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150